Nuvaira, Inc.   Report issue

For profit Phase 1
Founded: Plymouth MN United States (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2016
NCT02872298
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Holaira | Nuvaira, Inc.

Active Ingredients

Drugs in Phase 1 Trials (3)

azithromycin (zithromax) (1 trial)

prednisone (meticorten) (1 trial)

tiotropium (spiriva) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 3